Dr. Reddy’s Laboratories, founded in 1984, is India’s second largest pharmaceutical company. It was the first pharmaceutical company from Asia Pacific (outside Japan) to be listed on the New York Stock Exchange. The company manufactures and markets API (bulk actives), finished dosages and biologics in over 100 countries worldwide. It also has a very promising drug discovery pipeline and employs 950 scientists.